Ropes & Gray Represents Bain Capital in its $3.3 Billion Acquisition of Mitsubishi Tanabe Pharma Corporation

Ropes & Gray is representing Bain Capital, a leading global private investment firm, in its agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group Corporation. The investment is being led by Bain Capital’s Private Equity teams in Asia and North America together with the firm’s Life Sciences team and values the business at approximately ¥510 billion ($3.3 billion). The signing of the definitive agreement was announced on February 7.

Founded in 1984, Bain Capital is one of the world’s leading private investment firms with 24 offices on four continents, more than 1,850 employees, and approximately $185 billion in assets under management.

Mitsubishi Tanabe Pharma Corporation (MTPC), the pharma arm of Mitsubishi Chemical Group (MCG), is one of the oldest pharmaceutical companies in the world, founded in 1678, and focusing on ethical pharmaceuticals. MTPC is headquartered in Doshomachi, Osaka, the birthplace of Japan’s pharmaceutical industry.

Ropes & Gray’s Tokyo team advising Bain Capital included private equity partner Tsuyoshi Imai, finance partner Ben Morris, and associates Lucas Adams, Takashi Nakamura and Alex Nakayama. Our London team advising on antitrust included litigation & enforcement partner Ruchit Patel and associates Olivia Bennett and Katie Gerasimidis.